Shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) have been assigned an average rating of “Hold” from the fourteen research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $36.80.
Several equities analysts have recently issued reports on the stock. BidaskClub lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday. ValuEngine raised shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 24th. Zacks Investment Research raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $30.00 price target for the company in a research report on Monday, February 18th. Deutsche Bank set a $32.00 price target on shares of Acadia Healthcare and gave the company a “hold” rating in a research report on Thursday, May 2nd. Finally, Robert W. Baird reduced their price target on shares of Acadia Healthcare from $40.00 to $38.00 and set a “neutral” rating for the company in a research report on Monday, March 4th.
Shares of ACHC stock traded down $0.14 during trading hours on Wednesday, hitting $33.78. 589,309 shares of the company’s stock traded hands, compared to its average volume of 974,821. Acadia Healthcare has a 12-month low of $24.27 and a 12-month high of $45.35. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of 15.08, a PEG ratio of 1.81 and a beta of 0.64. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.07 and a current ratio of 1.07.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, April 30th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. Acadia Healthcare had a negative net margin of 6.50% and a positive return on equity of 7.33%. The firm had revenue of $760.60 million during the quarter, compared to analyst estimates of $762.02 million. During the same period last year, the business earned $0.52 earnings per share. The business’s revenue was up 2.5% on a year-over-year basis. As a group, sell-side analysts forecast that Acadia Healthcare will post 2.21 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Marshall Wace North America L.P. purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at $1,342,000. Clearbridge Investments LLC purchased a new stake in Acadia Healthcare in the 1st quarter worth $12,709,000. Nordea Investment Management AB lifted its stake in Acadia Healthcare by 1.3% in the 1st quarter. Nordea Investment Management AB now owns 140,136 shares of the company’s stock worth $4,107,000 after purchasing an additional 1,758 shares in the last quarter. Maverick Capital Ltd. lifted its stake in Acadia Healthcare by 8.1% in the 1st quarter. Maverick Capital Ltd. now owns 89,770 shares of the company’s stock worth $2,631,000 after purchasing an additional 6,700 shares in the last quarter. Finally, Man Group plc lifted its stake in Acadia Healthcare by 63.7% in the 1st quarter. Man Group plc now owns 51,922 shares of the company’s stock worth $1,522,000 after purchasing an additional 20,199 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
See Also: What are Institutional Investors?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.